Dutch cultivated meat startup Meatable is winding down operations after failing to secure necessary funding from existing or new investors, as announced by its major stakeholder Agronomics on December 19, 2025. Despite raising over €85 million since its 2018 founding and holding unique patents for growing muscle and fat cells from pluripotent stem cells, the company faced significant financial and strategic hurdles throughout 2025. The shutdown follows recent milestones, including the acquisition of Uncommon Bio, the appointment of a new CEO, and a partnership to build a production facility in Singapore. Consequently, Agronomics will write down its €13.6 million stake to zero, marking a significant shift for the sector and the loss of a pioneer that hosted the EU’s first legally approved cultivated meat tasting.
